BTLA Antikörper (C-Term)
Kurzübersicht für BTLA Antikörper (C-Term) (ABIN7180133)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from C-terminal of Human BTLA.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:3000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- BTLA
-
Hintergrund
-
Background: Lymphocyte inhibitory receptor which inhibits lymphocytes during immune response.
Watanabe N., Nat. Immunol. 4:670-679(2003).
Mao Y., Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
Oaks M.K., Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.Aliases: B and T lymphocyte associated protein antibody, B and T lymphocyte attenuator antibody, B and T lymphocyte associated antibody, B- and T-lymphocyte attenuator antibody, B- and T-lymphocyte-associated protein antibody, BTLA antibody, BTLA_HUMAN antibody, BTLA1 antibody, CD272 antibody, CD272 antigen antibody, FLJ16065 antibody, MGC129743 antibody
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-